{
  "ticker": "JAT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968633",
  "id": "02968633",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250711",
  "time": "1359",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250711/pdf/06lqc6ld23n5n0.pdf",
  "summary": "**Jatcorp Limited (ASX: JAT) \u2013 Preliminary FY2025 Unaudited Loss Guidance**  \n\n- **Expected FY2025 Net Loss After Tax**: $7.6M\u2013$8.0M (unaudited), representing a **material decline** vs. FY2024.  \n  - **H2 FY2025 Loss**: $1.5M\u2013$1.9M (unaudited) vs. $6.1M loss in H1 FY2025.  \n\n**Key Drivers of Loss**:  \n- **Revenue Decline**: Down ~$39M due to:  \n  - Cessation of international trading operations.  \n  - Suspension of Neurio-branded product sales in China (Neurio Dispute impact).  \n- **Impairments**: $2.3M goodwill + $0.2M trade names (Sunnya CGU) due to low Neurio sales.  \n- **Inventory Write-Downs**: ~$1.4M (non-cash), mainly Neurio-related excess stock.  \n- **Legal Costs**: $4.1M (Neurio dispute, though $1M lower YoY).  \n\n**FY2026 Outlook**:  \n- Focus on Moroka\u00ae brand growth (H&S International distributor targeting $11M sales, +22% YoY).  \n- No quantitative guidance; audited FY2025 results pending.  \n\n**No material information identified** in the \"Registered office\" correction.  \n\n*(Note: Omitted operational/strategic boilerplate; emphasis on financial impact.)*",
  "usage": {
    "prompt_tokens": 1364,
    "completion_tokens": 327,
    "total_tokens": 1691,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-11T05:15:49.871721"
}